Cue Biopharma Inc at JMP Securities Life Sciences Conference Transcript
So good afternoon, everyone. And welcome to the JMP Securities Life Sciences Conference. It's my pleasure to introduce Cue Biopharma. Cue Biopharma is a unique biopharmaceutical company, developing technologies to harness the power of IL-2 in a targeted manner.
And so presenting for the company is Dan Passeri, CEO. Dan, welcome.
Thanks, Reni. Thank you. It's good being here.
Questions & Answers
As I've filled all the CEOs that I'm talking to, I have no idea who's in the audience, let alone who's hitting the replay button. And so, for those who don't know the Cue Biopharma story, can you give us an overview in three to five minutes?
Sure. So Cue is basically formed out of the Albert Einstein College of Medicine. And its core competency in the early days of protein
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |